
Keywords: پاسخگویی به تغییر; localized scleroderma; measurement; minimal clinically important difference; outcomes; responsiveness to change; validity; CARRA; Childhood Arthritis and Research Alliance; CDLQI; Children's Dermatology Life Quality Index; ECM; extracutaneous manifestatio